Genetic Signatures

Genetic Signatures Limited – Annual Report 2021 Consolidated Statement of Changes in Equity CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE FINANCIAL YEAR ENDED 30 JUNE 2021 19 Consolidated Issued Capital Share based payments reserve Foreign currency translation reserve Accumulated losses Total $’000s $’000s $’000s $’000s $’000s Balance at 1 July 2019 47,028 1,413 (44) (37,828) 10,569 Loss attributable to members of the entity - - - (2,086) (2,086) Other comprehensive income/(loss) - - (111) - (111) Total comprehensive income/(loss) for the year - - (111) (2,086) (2,197) Transactions with owners in their capacity as owners: Contributions of equity, net of transaction costs (note 15) 35,608 - - - 35,608 Repayment of loans against shares (note 15) 1,234 - - - 1,234 Share issues on conversion of options 143 - - - 143 Forfeiture of share-based payments (note 16) - (59) - - (59) Share-based payments (note 16) - 631 - - 631 Balance at 30 June 2020 84,013 1,985 (155) (39,914) 45,929 Profit attributable to members of the entity - - - 1,756 1,756 Other comprehensive income/(loss) - - 20 - 20 Total comprehensive income/(loss) for the year - - 20 1,756 1,776 Transactions with owners in their capacity as owners: Share issues on conversion of options, net of costs (note 15) 151 - - - 151 Forfeiture of share-based payments (note 16) - (235) - - (235) Share-based payments (note 16) - 1,719 - - 1,719 Balance at 30 June 2021 84,164 3,469 (135) (38,158) 49,340 The above consolidated statement of changes in equity should be read in conjunction with the accompanying notes Financial Report